Page last updated: 2024-09-05

regadenoson and temozolomide

regadenoson has been researched along with temozolomide in 3 studies

Compound Research Comparison

Studies
(regadenoson)
Trials
(regadenoson)
Recent Studies (post-2010)
(regadenoson)
Studies
(temozolomide)
Trials
(temozolomide)
Recent Studies (post-2010) (temozolomide)
321532646,0148264,331

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Anders, NM; Brem, H; Grossman, SA; Jackson, S; Liu, A; Mangraviti, A; Rudek, MA; Sankey, EW; Tyler, B; Wanjiku, TM1
Anders, NM; Figg, WD; George, RT; Gilbert, M; Grossman, SA; Harfi, TT; Jackson, S; McAreavey, D; Nduom, EK; Peer, C; Rudek, MA; Weingart, J; Ye, X1

Reviews

1 review(s) available for regadenoson and temozolomide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for regadenoson and temozolomide

ArticleYear
The effect of an adenosine A
    Fluids and barriers of the CNS, 2018, Jan-15, Volume: 15, Issue:1

    Topics: Adenosine A2 Receptor Agonists; Administration, Intravenous; Administration, Oral; Adult; Aged; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Feasibility Studies; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Purines; Pyrazoles; Receptor, Adenosine A2A; Temozolomide

2018

Other Studies

1 other study(ies) available for regadenoson and temozolomide

ArticleYear
The effect of regadenoson-induced transient disruption of the blood-brain barrier on temozolomide delivery to normal rat brain.
    Journal of neuro-oncology, 2016, Volume: 126, Issue:3

    Topics: Animals; Antineoplastic Agents, Alkylating; Blood-Brain Barrier; Brain; Dacarbazine; Drug Delivery Systems; Female; Purines; Pyrazoles; Rats; Rats, Inbred F344; Tandem Mass Spectrometry; Temozolomide; Tissue Distribution

2016